HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mouse knockout of the cholesterogenic cytochrome P450 lanosterol 14alpha-demethylase (Cyp51) resembles Antley-Bixler syndrome.

Abstract
Antley-Bixler syndrome (ABS) represents a group of heterogeneous disorders characterized by skeletal, cardiac, and urogenital abnormalities that have frequently been associated with mutations in fibroblast growth factor receptor 2 or cytochrome P450 reductase genes. In some ABS patients, reduced activity of the cholesterogenic cytochrome P450 CYP51A1, an ortholog of the mouse CYP51, and accumulation of lanosterol and 24,25-dihydrolanosterol has been reported, but the role of CYP51A1 in the ABS etiology has remained obscure. To test whether Cyp51 could be involved in generating an ABS-like phenotype, a mouse knock-out model was developed that exhibited several prenatal ABS-like features leading to lethality at embryonic day 15. Cyp51(-/-) mice had no functional Cyp51 mRNA and no immunodetectable CYP51 protein. The two CYP51 enzyme substrates (lanosterol and 24,25-dihydrolanosterol) were markedly accumulated. Cholesterol precursors downstream of the CYP51 enzymatic step were not detected, indicating that the targeting in this study blocked de novo cholesterol synthesis. This was reflected in the up-regulation of 10 cholesterol synthesis genes, with the exception of 7-dehydrocholesterol reductase. Lethality was ascribed to heart failure due to hypoplasia, ventricle septum, and epicardial and vasculogenesis defects, suggesting that Cyp51 deficiency was involved in heart development and coronary vessel formation. As the most likely downstream molecular mechanisms, alterations were identified in the sonic hedgehog and retinoic acid signaling pathways. Cyp51 knock-out mice provide evidence that Cyp51 is essential for embryogenesis and present a potential animal model for studying ABS syndrome in humans.
AuthorsRok Keber, Helena Motaln, Kay D Wagner, Nataša Debeljak, Minoo Rassoulzadegan, Jure Ačimovič, Damjana Rozman, Simon Horvat
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 286 Issue 33 Pg. 29086-29097 (Aug 19 2011) ISSN: 1083-351X [Electronic] United States
PMID21705796 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CYP51A1 protein, human
  • Hedgehog Proteins
  • Shh protein, mouse
  • Lanosterol
  • Tretinoin
  • lanostenol
  • Cholesterol
  • Cyp51 protein, mouse
  • Sterol 14-Demethylase
  • Oxidoreductases Acting on CH-CH Group Donors
  • 7-dehydrocholesterol reductase
  • Fgfr2 protein, mouse
  • Receptor, Fibroblast Growth Factor, Type 2
Topics
  • Animals
  • Antley-Bixler Syndrome Phenotype
  • Cholesterol (biosynthesis, genetics)
  • Disease Models, Animal
  • Embryo, Mammalian (enzymology)
  • Embryonic Development (genetics)
  • Heart Failure (enzymology, genetics, metabolism)
  • Hedgehog Proteins (genetics, metabolism)
  • Humans
  • Lanosterol (analogs & derivatives, genetics, metabolism)
  • Mice
  • Mice, Knockout
  • Oxidoreductases Acting on CH-CH Group Donors (genetics, metabolism)
  • Pericardium (enzymology)
  • Receptor, Fibroblast Growth Factor, Type 2 (genetics, metabolism)
  • Signal Transduction (genetics)
  • Sterol 14-Demethylase (genetics, metabolism)
  • Tretinoin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: